| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 04/08/2010 | US20100087372 Growth hormone secretion stimulator |
| 04/07/2010 | EP2172454A1 Benzimidazole derivative |
| 04/07/2010 | EP2172453A1 COMPOUND HAVING 11 ß-HSD1 INHIBITORY ACTIVITY |
| 04/07/2010 | EP2172197A1 Octanoic acid derivative to treat fibromyalgia and other pains |
| 04/07/2010 | EP2170925A2 17ß -CYANO-19-NOR-ANDROST-4-ENE DERIVATIVE, USE THEREOF AND MEDICAMENTS CONTAINING SAID DERIVATIVE |
| 04/07/2010 | EP1530470B9 Selective estrogen receptor modulators containing a phenylsulfonyl group |
| 04/07/2010 | CN101691410A Marine oligosaccharide chromic compound having function of preventing and treating insulin resistance |
| 04/07/2010 | CN101690815A Novel use of dipeptidyl peptidase-iv inhibitor |
| 04/07/2010 | CN101690778A Chinese medicinal preparation for treating insulin resistance symptoms and preparation method thereof |
| 04/06/2010 | US7691974 Botulinum neurotoxin type E having increased biological half-life for use treatment and prevention of autonomic, neuromuscular and pain disorders |
| 04/06/2010 | US7691967 Smart pro-drugs of serine protease inhibitors |
| 04/06/2010 | US7691421 Comprising Cucurbita moschata, Carthamus tinctorius, Plantago asiatica and Lonicera japonica; climacteric disturbance, primary hypogonadism (including ovarian hypofunction and testicular deficiency), Turner's syndrome, Klinefelter's syndrome, gonadotropin-producing tumor, testitis, ovarian amenorrhea |
| 04/06/2010 | US7691411 Pharmaceutical formulae for thyroid hormones and procedures for obtaining them |
| 04/06/2010 | US7691408 Composition having gelling properties for the prolonged delivery of bioactive substances |
| 04/06/2010 | CA2455181C Benzimidazo[4,5-f]isoquinolinone derivatives |
| 04/06/2010 | CA2397636C Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 04/01/2010 | WO2010037129A1 Quinazolinone, quinolone and related analogs as sirtuin modulators |
| 04/01/2010 | WO2010035806A1 Solid pharmaceutical composition |
| 04/01/2010 | WO2010034707A1 Substituted purinyl-pyrazol derivatives and their use as potassium channel modulators |
| 04/01/2010 | WO2009158007A3 Methods and compositions for therapeutic treatment |
| 04/01/2010 | US20100081670 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 04/01/2010 | US20100081660 Novel Compounds Having Selective Inhibiting Effect at GSK3 |
| 04/01/2010 | US20100081622 Reduction of parathyroid hormone levels |
| 04/01/2010 | CA2738809A1 Quinazolinone, quinolone and related analogs as sirtuin modulators |
| 04/01/2010 | CA2738147A1 Solid pharmaceutical composition |
| 03/31/2010 | EP2168984A1 Human antibodies that bind human IL-12 and methods for producing |
| 03/31/2010 | EP2168948A1 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors |
| 03/31/2010 | EP2167136A2 Molecules for targeting compounds to various selected organs or tissues |
| 03/31/2010 | EP2167112A2 Cyclic peptide melanocortin receptor ligands |
| 03/31/2010 | CN101687904A Fatty acid esters of glucocorticoids as anti-inflammatory and anti-cancer agents |
| 03/31/2010 | CN101687902A 8-beta-substituted estratrienes as selectively active estrogens |
| 03/31/2010 | CN101687810A Bicyclic compound and pharmaceutical use thereof |
| 03/31/2010 | CN101687019A Medicaments and methods to treat autoimmune disease and cancer |
| 03/31/2010 | CN101684158A Binding domain-immunoglobulin fusion proteins |
| 03/31/2010 | CN101683530A Novel ppar ligands that do not cause fluid retention, edema or congestive heart failure |
| 03/31/2010 | CN101683317A 缓释组合物 Sustained release composition |
| 03/30/2010 | US7687507 Protein tyrosine kinase, such as Janus Kinase 3, inhibitors, immunosuppressants; organ transplants, lupus, multiple sclerosis, psoriasis; antidiabetic agents, antiarthritic agents, anticarcinogenic agents, Alzheimer's Disease, Crohn's Disease, Inflammatory Bowel Disease, autoimmune thyroid disorders |
| 03/30/2010 | US7687485 Formulation for menopausal women |
| 03/30/2010 | CA2453312C Therapeutic agent delivery tampon |
| 03/30/2010 | CA2372633C Staphylococcus aureus antigen-containing whole cell vaccine |
| 03/25/2010 | WO2010032200A1 Amide compounds useful in therapy |
| 03/25/2010 | WO2010008733A3 Solid forms of (1r,2s,3r)-1-(2-(isoxazol-3-yl)-1h-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their use |
| 03/25/2010 | US20100076071 Use of equol for treating skin diseases |
| 03/25/2010 | US20100075989 Novel Compounds Having Selective Inhibiting Effect at GSK3 |
| 03/25/2010 | CA2735931A1 Amide compounds useful in therapy |
| 03/24/2010 | EP2164519A2 Long-acting polymeric prodrugs of exendin |
| 03/24/2010 | EP1389110B1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/24/2010 | CN101679478A 17ss-cyano-19-nor-androst-4-ene derivative, use thereof and medicaments containing said derivative |
| 03/24/2010 | CN101679477A 17beta-cyano-18a-homo-19-nor-androst-4-ene derivative, use thereof and medicaments containing said derivative |
| 03/24/2010 | CN101679455A New progesterone receptor modulators |
| 03/24/2010 | CN101679326A Substituted phenoxy n-alkylated thiazoledinedione as estrogen related receptor-alpha modulators |
| 03/24/2010 | CN101679317A Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid r |
| 03/24/2010 | CN101678022A 5-cyan0-4- (pyrrolo [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors |
| 03/24/2010 | CN101677958A Oral pharmaceutical preparation for colon-specific delivery |
| 03/24/2010 | CN101676298A 黑皮质素受体配体 Melanocortin receptor ligands |
| 03/24/2010 | CN101676255A Synthetic method of iodized vegetable fatty acids and their esters |
| 03/24/2010 | CN101675927A therapeutic molecules and methods-1 |
| 03/24/2010 | CN100595211C Angiopoietin-2 specific binding agents |
| 03/24/2010 | CN100594907C Pharmaceutical formulation for contraception and hormone-replacement therapy |
| 03/23/2010 | US7683074 Antiinflammatory agents; antiallergens; neurodegrative disease ; autoimmune disease; antiarthritic agents |
| 03/23/2010 | US7683052 Crystalline polymorph of bazedoxifene acetate |
| 03/23/2010 | US7683051 Crystalline polymorph of bazedoxifene acetate |
| 03/23/2010 | CA2372994C Implantable gel compositions and method of manufacture |
| 03/18/2010 | WO2010030787A1 Estrogen receptor ligands |
| 03/18/2010 | WO2009134380A8 Super fast-acting insulin compositions |
| 03/18/2010 | WO2009078012A3 Methods of generating expanded and re-differentiated adult islet beta cells for use in the treatment of diabetes |
| 03/18/2010 | US20100069379 Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 03/18/2010 | US20100068273 Pharmaceutical formulation, its use, and method for its manufacture |
| 03/18/2010 | US20100068177 Methods of organ regeneration |
| 03/17/2010 | EP1455847B1 Feminine care products for the delivery of therapeutic substances |
| 03/17/2010 | EP1315502B1 Method for treating erectile dysfunction and increasing libido in men |
| 03/17/2010 | CN101671393A Angiopoietin-2 specific binding agents |
| 03/17/2010 | CN101671260A Method for preparing O-desmethyl-venlafaxine |
| 03/17/2010 | CN101670023A Medicament for treating hyperprolactinemia, preparation method thereof and use thereof |
| 03/17/2010 | CN101670003A Chinese medicinal preparation for treating endocrine disorder |
| 03/17/2010 | CN101669936A Drug combination containing pratensein and application thereof in drugs |
| 03/17/2010 | CN101669935A Drug combination containing prunetin and application thereof in drugs |
| 03/17/2010 | CN101669934A Suppressive activity of mango aglycone on PTP1B and application thereof |
| 03/17/2010 | CN101669900A Polymeric delivery formulations of leuprolide with improved efficacy |
| 03/16/2010 | US7678378 Compounds for intracellular delivery of therapeutic moieties to nerve cells |
| 03/16/2010 | CA2431521C Steroid hormone products and methods for preparing them |
| 03/16/2010 | CA2336846C Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric g protein |
| 03/16/2010 | CA2329881C Compounds with growth hormone releasing properties |
| 03/11/2010 | WO2010027500A1 Aminotriazolopyridines and their use as kinase inhibitors |
| 03/11/2010 | WO2010027498A2 Compositions and methods for inducing satiety and treating non-insulin dependent diabetes emillitus, pre-diabetic symptoms, insulin resistance and related disease states and conditions |
| 03/11/2010 | WO2010027002A1 Ring-fused morpholine derivative having pi3k-inhibiting activity |
| 03/11/2010 | WO2010025632A1 A methods for preparing the clathrate compound of steroid medicines utilizing hydrotalcite as carrier |
| 03/11/2010 | US20100063079 Pyrimidyl Sulphone Amide Derivatives as Chemokine Receptor Modulators |
| 03/11/2010 | US20100063075 Aryl-quinazoline/aryl-2amino-phenyl methanone derivatives |
| 03/11/2010 | US20100063019 Low Dose Estrogen Interrupted Hormone Replacement Therapy |
| 03/11/2010 | CA2735806A1 Aminotriazolopyridines and their use as kinase inhibitors |
| 03/10/2010 | EP2161265A2 Compounds having selective inhibiting effect at GSK3 |
| 03/10/2010 | EP1377293B1 Aryl and biaryl piperidines used as mch antagonists |
| 03/10/2010 | CN101664388A transnasal transport/immunisation with highly adaptable carriers |
| 03/09/2010 | US7674909 Tetrahydroquinoline derivatives and their use as FSH receptor modulators |
| 03/09/2010 | US7674773 Glycosylated derivative of hypolipemic agents; side effect reduction; therapy for insulin resistance; hyperlipidemia agent; impaired lipid metabolism; lowering cholesterol levels |
| 03/09/2010 | US7674463 Method of inhibiting angiogenesis by administration of a corticotropin releasing factor receptor 2 agonist |
| 03/09/2010 | CA2379282C Amido spiropiperidines promote the release of growth hormone |
| 03/04/2010 | WO2010023572A1 Herbal extract as sensitivity enhancer toward insulin and antidiabetes |
| 03/04/2010 | WO2010022497A1 Method of treating dysglycemia and glucose excursions |